Physician profile
Subir Bhatia
NPI 1164885158
$3,632.99
in general payments reported to CMS, 2019-2025
24 companies · $935 in 2025
The $935 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $237 · 2021: $1,142 · 2022: $592 · 2023: $320 · 2024: $157 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,022.39 | 2020-2025 | Aveir, Coroflow, Xience Sierra |
| Abiomed | $471.78 | 2023-2025 | Impella |
| Boston Scientific Corporation | $358.34 | 2019-2025 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $355.71 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $294.78 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $172.00 | 2019-2023 | |
| Penumbra, INC. | $150.83 | 2025 | Indigo System |
| Medtronic, INC. | $104.00 | 2021-2022 | |
| Amgen INC. | $102.40 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $76.85 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $57.79 | 2019-2021 | |
| Pfizer INC. | $54.92 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $54.30 | 2022-2023 | Camzyos |
| Astellas Pharma US INC | $53.41 | 2021 | |
| Novo Nordisk INC | $50.80 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $49.85 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $34.01 | 2025 | Assure Wcd |
| Philips North America LLC | $28.06 | 2021 | |
| Medtronic Vascular, INC. | $27.69 | 2020 | |
| United Therapeutics Corporation | $27.04 | 2021 | |
| Biosense Webster, INC. | $23.94 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.69 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.93 | 2021 | |
| Elutia, INC. | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subir Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.